Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: history of present illness: ms. is a 53-year-old female with history of stage iiia and ib melanoma with new retroperitoneal, pelvic and inguinal lymphadenopathy. she underwent excisional biopsy of a 2.1-mm thick melanoma from her right ankle in the spring of . she underwent wide local excision, skin flap and right inguinal sentinel lymph node biopsy without residual melanoma at the primary site. two sentinel lymph nodes showed evidence of microscopic involvement with melanoma. her postoperative course was complicated by failure of the flap to take. dr. performed a right superficial inguinal femoral lymphadenectomy with right sartorius rotation flap on with pathology showing microscopic melanoma in residual lymph nodes. she began adjuvant interferon in , undergoing 2 dose reductions due to peripheral neuropathy and persistent back pain. she completed 39 weeks of interferon. she underwent skin biopsy of a left posterior thigh lesion in revealing a 0.62-mm thick superficial spreading melanoma, level iv without ulceration for which she underwent re-excision on without residual melanoma noted. she developed worsening right lower extremity edema in late with abdominal pelvic ct revealing retroperitoneal and pelvic lymphadenopathy. she underwent ct-guided biopsy of a pelvic node revealing metastatic melanoma. she was screened for high- dose il-2 therapy and underwent prescreening testing. she now is admitted to begin cycle 1 week on high-dose il-2 therapy. past medical history: cervical dysplasia treated with colonoscopy, cervical neck disk disease treated with surgery, lumbar spine disk herniation, a history of depression. allergies: no known drug allergies. social history: lives with significant other, smokes, currently on disability, no etoh. medications on admission: wellbutrin sr 200 mg daily, klonopin 0.5 mg at bedtime, 0.25 mg t.i.d. p.r.n., premarin 0.625 mg cream, lexapro 20 mg daily, nexium 40 mg p.o. daily, lorazepam 1 mg t.i.d. p.r.n., percocet 1-2 tablets every 4 hours p.r.n. pain, calcium 500 mg daily, multivitamin 1 tablet daily. physical examination: general: well-appearing female in no acute distress. vital signs: stable. heent: clear. heart: regular rate and rhythm. chest: clear bilaterally. abdomen: palpable lower abdominal masses. extremities: 3+ right lower extremity edema. labs on admission: wbc 11.2, hemoglobin 10.9, hematocrit 31.6, platelet count 496,000, bun 17, creatinine 0.8, sodium 137, potassium 3.9, chloride 99, co2 30, glucose 86 inr 1.1, alt 10, ast 16, albumin 3.8. hospital course: ms. was admitted and underwent central line placement to begin therapy. her admission weight was 68 kg and she received interleukin ii 600,000 international units per kilo equaling 40.8 million units iv every 8 hours times 14 potential doses. during this week she received doses with 2 doses held related to shortness of breath on treatment day #5. she stabilized on treatment day #6 but that evening developed increasing shortness of breath associated with hypoxia requiring 100% non-rebreather with o2 sats in the mid 90s consistent with acute pulmonary edema. chest x-ray was consistent with that and she was treated with lasix with good urine output. that night on treatment day #7 she desatted to 80% on a non-rebreather and was transferred to the icu where continued diuresis was carried out. ____________ edema. she was tried on cpap which she did not tolerate well and was placed back on 100% non- rebreather. she did not require intubation. she slowly improved with diuresis and was transferred back to 7 on where she continued to improve with eventual discharge on . other side effects during il-2 therapy included rigors improved with demerol; development of an erythematous pruritic skin rash; mild nausea improved with antiemetic therapy; and diarrhea improved with lomotil therapy. during this week she had no acute renal failure noted. she developed transaminitis with a peak alt of 87 and peak ast of 99, both improved at the time of discharge. she developed hyperbilirubinemia with peak bilirubin of 4 improved to 1 at the time of discharge. she was anemic without need for packed red blood cell transfusion. she developed thrombocytopenia with a platelet count low of 11,000, improved to 111,000 at the time of discharge. she had no coagulopathy or myocarditis noted. by she had recovered from side effects to allow for discharge to home. condition on discharge: stable. discharge status: to home with her significant other. discharge diagnoses: metastatic melanoma status post cycle 1 week on high-dose il-2 therapy complicated by acute pulmonary edema. discharge medications: wellbutrin 200 mg p.o. daily, nexium 40 mg p.o. daily, lexapro 20 mg p.o. daily, percocet 1-2 tablets every 4 hours p.r.n. pain, ativan 1 mg every 6 hours p.r.n. anxiety. outpatient physical therapy. follow-up plans: ms. will recover from her complicated first week of high-dose il-2 therapy. week 2 of therapy will not be administered at this time but we will plan to follow up with ct scans at week 7 to assess disease response to determine whether treatment again would be warranted. , dictated by: medquist36 d: 11:12:09 t: 14:08:25 job#: procedure: venous catheterization, not elsewhere classified high-dose infusion interleukin-2 [il-2] diagnoses: toxic encephalopathy hypopotassemia acute respiratory failure antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally personal history of malignant melanoma of skin secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acute edema of lung, unspecified secondary and unspecified malignant neoplasm of lymph nodes of inguinal region and lower limb secondary and unspecified malignant neoplasm of intrapelvic lymph nodes mucositis (ulcerative) due to antineoplastic therapy other specified aplastic anemias encounter for antineoplastic immunotherapy 

Answer: The patient is high likely exposed to